From left to right: Christian Kessler, Evonik, Head of Incubation Cluster Life Sciences, Creavis; Kevin Kuros, Massachusetts Office of Business Development, Central Massachusetts Regional Director; Guido Skudlarek, Evonik, President North America; Robert Langer, MIT, David H. Koch Institute Professor; Ralph Marquardt, Evonik, Chief Innovation Officer; Anne White, MIT, Associate Vice President for Research Administration and School of Engineering Distinguished Professor of Engineering; Anil Saxena, Evonik, Head of Research, Development & Innovation (RD&I) North America. Credits: Evonik.

Germany’s strategic innovation unit and business incubator, Evonik Creavis, has opened a new satellite innovation facility in Cambridge, in the US state of Massachusetts.

The facility, named Satellite Innovation, includes both labs and offices. Initially, Satellite Innovation will focus on research and development (R&D) activities for healthcare innovations such as nucleic acid-based medicines.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The new facility will also accelerate Evonik’s venture capital activities in the life sciences sector in the region. The investments will be focused on drug delivery technologies, cell culture, tissue engineering, and medical implants.

Anil Saxena, head of the facility said, “With our new Innovation Satellite in Cambridge, we are extending an invitation for collaboration to the brilliant minds across this dynamic region.”

Ralph Marquardt, chief innovation officer of Evonik said, “Addressing the global challenges of our time requires the worldwide collaboration of competent partners, and we are looking forward to jointly developing innovative solutions. We are strengthening regional R&D in North America and Asia to benefit from innovative ideas outside of Europe and be closer to our customers in those regions,”

Creavis’ Cambridge Innovation Satellite adds to Evonik’s ongoing R&D expansion in the US. In March 2023, the company broke ground on a new $220m lipid innovation centre in Lafayette, Indiana. Furthermore, in September 2022, it opened a new innovation hub in Allentown, Pennsylvania.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Headquartered in the German city of Essen, Evonik Industries AG has production plants in over 27 countries with around 33,000 employees globally.